A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03126019. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma.
Study identification
- NCT ID
- NCT03126019
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2018 (Actual)
- Primary completion
- Feb 26, 2021 (Actual)
- Completion
- Jun 7, 2024 (Actual)
- Last update posted
- Mar 14, 2025
2018 – 2024
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates - Biltmore Cancer Center | Phoenix | Arizona | 85016 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Synergy Hematology and Oncology Medical Associates | Los Angeles | California | 90036 | — |
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| American Institute of Research Corporate Office | Whittier | California | 90603 | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | 06489 | — |
| Florida Cancer Specialists & Research Institute | Fort Myers | Florida | 33901 | — |
| Asclepes Research Centers | Spring Hill | Florida | 34606 | — |
| Clinical Trials of Swla Llc | Lake Charles | Louisiana | 70601 | — |
| Saint Agnes Hospital | Baltimore | Maryland | 21229 | — |
| Barbara Ann Karmanos Cancer Hospital | Detroit | Michigan | 48201 | — |
| Hattiesburg Clinic Hematology | Hattiesburg | Mississippi | 39401 | — |
| Saint Luke'S Hospital | Kansas City | Missouri | 64111 | — |
| Sarah Cannon Research Institute | Kansas City | Missouri | 64132 | — |
| Clinical Research Alliance, Inc. | New Hyde Park | New York | 11042 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | — |
| Charleston Hematology Oncology Associates Pa | Charleston | South Carolina | 29414 | — |
| Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Renovatio Clinical Consultants Llc | Spring | Texas | 77380 | — |
| University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03126019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2025 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.